Antibodies and neuronal autoimmune disorders of the CNS

  title={Antibodies and neuronal autoimmune disorders of the CNS},
  author={Francesc Graus and Albert Saiz and Josep Dalmau},
  journal={Journal of Neurology},
We review the neuronal antibodies described in CNS disorders in order to clarify their diagnostic value, emphasize potentials pitfalls and limitations in the diagnosis of paraneoplastic neurological syndromes (PNS), and examine the current evidence for a possible pathogenic role. We propose to classify the neuronal antibodies associated with syndromes resulting from CNS neuronal dysfunction into two groups according to the location of the antigen: inside the neuron or in the cell membrane… 

Clinical neuropathology practice guide 5-2012: Updated guideline for the diagnosis of anti-neuronal antibodies

Different techniques are established for detecting anti-neuronal antibodies: tissue-based assay, cell- based assay, immunoblot, immunoprecipitation assay, and ELISA, which may be useful for the detection of specific antibodies or to solve particular issues such as antibody titers.

Antibody testing in peripheral nerve disorders.

Central nervous system neuronal surface antibody-associated syndromes. Clinical and Laboratory Characterization

The aim of the research performed in the three years of PhD study has been to characterize NSAS from both a laboratory and a clinical point of view, and designed guidelines for recognizing these and other immune-mediated conditions in the future.

Central nervous system neuronal surface antibody associated syndromes: review and guidelines for recognition

The concept of antibody mediated CNS disorders is relatively recent. The classical CNS paraneoplastic neurological syndromes are thought to be T cell mediated, and the onconeural antibodies merely

Neuron-directed autoimmunity in the central nervous system: entities, mechanisms, diagnostic clues, and therapeutic options.

An overview of neuron-directed autoimmunity as a novel class of inflammatory CNS disorders, their differential diagnoses, clinical hallmarks, imaging features, characteristic laboratory, electrophysiological, cerebrospinal fluid and neuropathological findings, cellular and molecular disease mechanisms, as well as therapeutic options are provided.

Autoimmune Epilepsies

Emerging findings in patients with immune-associated disorders of the gray central nervous system matter make it plausible that immunological therapies, preferably early after characterization of the antibodies, offer opportunities to restore the health of affected patients.

New concepts in paraneoplastic neurological syndromes.

Paraneoplastic and non-paraneoplastic autoimmunity to neurons in the central nervous system

This work provides an overview of entities, clinical hallmarks, imaging features, characteristic laboratory, electrophysiological, cerebrospinal fluid and neuropathological findings, cellular and molecular disease mechanisms as well as therapeutic options in these two broad categories of inflammatory CNS disorders.

Antineuronal autoantibodies in neurological disorders

  • K. Bürk
  • Biology, Medicine
    Biomolecular concepts
  • 2011
The review gives an overview of the common characteristics of each group and provides more detailed information on single abs and the associated clinical syndromes.



Antibodies to a subpopulation of glial cells and a 66 kDa developmental protein in patients with paraneoplastic neurological syndromes.

The detection of anti-CV2 antibodies in patients with neurological disorders should be considered as an indication of the presence of an occult cancer.

Neuronal surface antigen antibodies in limbic encephalitis

In paraneoplastic limbic encephalitis (LE), novel antibodies against neuronal surface Antigens (nNSA-ab) occur frequently, coexist with antibodies against intracellular antigens, and these cases are refractory to immunotherapy.

Paraneoplastic limbic encephalitis associated with potassium channel antibodies: value of anti-glial nuclear antibodies in identifying the tumour

Two patients with paraneoplastic limbic encephalitis associated with SCLC and VGKC-ab are reported on who also presented AGNA and an immunohistochemical competition assay was performed to confirm AGNA reactivity.

Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome

The autoantibody profiles observed in patients with paraneoplastic disorders imply the targeting of multiple onconeural antigens and predict the patient's neoplasm, but not a specific neurological syndrome.

Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.

The demonstration of an increased IS of GAD-ab is important to confirm that the GAD autoimmunity is related to the neurological syndrome particularly when there is a concomitant DM1 that could justify the presence of high G AD-ab levels.

Anti-glial nuclear antibody: Marker of lung cancer-related paraneoplastic neurological syndromes

Antibodies to Zic4 in paraneoplastic neurologic disorders and small-cell lung cancer

In patients with neurologic symptoms of unknown cause detection of Zic4 antibodies predicts a neoplasm, usually a SCLC, and suggests that the neurologic disorder is paraneoplastic.